ICU Medical, Inc. (NASDAQ:ICUI) COO Christian B. Voigtlander Sells 4,945 Shares

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) COO Christian B. Voigtlander sold 4,945 shares of the firm's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $131.00, for a total transaction of $647,795.00. Following the sale, the chief operating officer now directly owns 5,513 shares in the company, valued at $722,203. This represents a 47.28% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

ICU Medical Stock Performance

ICUI traded down $2.73 during trading hours on Wednesday, hitting $127.72. 55,063 shares of the stock were exchanged, compared to its average volume of 276,698. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a 12 month low of $100.91 and a 12 month high of $196.26. The stock has a 50-day simple moving average of $138.87 and a 200-day simple moving average of $151.88. The stock has a market cap of $3.14 billion, a price-to-earnings ratio of -27.95 and a beta of 0.87.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 EPS for the quarter, beating the consensus estimate of $1.23 by $0.49. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. The company had revenue of $599.49 million during the quarter, compared to analyst estimates of $574.15 million. During the same period in the prior year, the company earned $0.96 earnings per share. The business's revenue was up 6.7% compared to the same quarter last year. Analysts anticipate that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

Institutional Investors Weigh In On ICU Medical

Institutional investors have recently bought and sold shares of the stock. Harvest Fund Management Co. Ltd acquired a new stake in shares of ICU Medical during the fourth quarter valued at approximately $33,000. Quarry LP raised its holdings in ICU Medical by 764.3% during the fourth quarter. Quarry LP now owns 242 shares of the medical instruments supplier's stock valued at $38,000 after buying an additional 214 shares in the last quarter. Murphy & Mullick Capital Management Corp acquired a new stake in shares of ICU Medical in the fourth quarter worth about $52,000. Venturi Wealth Management LLC boosted its stake in shares of ICU Medical by 64.0% during the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after acquiring an additional 206 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its holdings in shares of ICU Medical by 88.8% during the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after acquiring an additional 300 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

Analysts Set New Price Targets

Several brokerages have weighed in on ICUI. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Wall Street Zen raised ICU Medical from a "hold" rating to a "buy" rating in a research report on Sunday, May 18th. KeyCorp reduced their target price on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Finally, Raymond James cut their price objective on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a research report on Friday, May 9th. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, ICU Medical has a consensus rating of "Buy" and a consensus target price of $192.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.